Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes

BACKGROUND AND PURPOSE: In a past study, we developed and optimized a novel cationic PEGylated niosome containing anticancer drugs (doxorubicin or quercetin) and siRNA. This study intended to evaluate the anti-tumor effects of the combination therapy to target both the proteins and genes responsible...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemati, Mahdie, Haghiralsadat, Fateme, Jafary, Farzaneh, Moosavizadeh, Seyedmohammad, Moradi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699499/
https://www.ncbi.nlm.nih.gov/pubmed/31616144
http://dx.doi.org/10.2147/IJN.S211844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699499/
https://www.ncbi.nlm.nih.gov/pubmed/31616144
http://dx.doi.org/10.2147/IJN.S211844

Ejemplares similares